trastuzumab-resistance - Globe Thesis

Keyword [trastuzumab-resistance] Result: 1 - 20 \| Page: 1 of 2
1.	Novel Role Of MiR-375in Trastuzumab-resistance And Metastasis Of HER2-positive Breast Cancer
2.	Acquisition Of Resistance To Trastuzumab In Gastric Cancer Cells Is Associated With Activation Of IL-6/STAT3/Jagged-1/Notch Positive Feedback Loop
3.	MiR-200c Suppresses TGF-β Signaling And Counteracts Trastuzumab Resistance And Metastasis By Targeting ZNF217 And ZEB1 In Breast Cancer
4.	Study On The Role Of PRAS40 Phosphorylation At Thr246 In The Development Of Trastuzumab Resistance In HER2-positive Breast Cancer
5.	Feedback Activation Of STAT3 Mediates Trastuzumab Resistance Via Upregulation Of MUC1 And MUC4 Expression
6.	A New Mechanism Of Trastuzumab Resistance In Gastric Cancer:MACC1 Promotes The Warburg Effect Via Activation Of The PI3K/AKT Signaling Pathway
7.	Autocrine Artemin And Prolactin In The Regulation Of Therapeutc Resistance Of Anti-cancer Drugs
8.	Targeted Treatment Of Breast Cancer And Acute Myeloid Leukemia
9.	Research On Inhibition On Herceptin-resistant And Functional Optimization Of Anti-HER3 Antibody
10.	Activation Of PI3K/AKT Pathway Promotes Trastuzumab Resistance In HER2-positive Gastric Cancer
11.	Finding Predictive Biomarkers For Trastuzumab Resistance In A Breast Cancer Cell Line
12.	PIK3R3-STAT3 Feedback Loop Mediates Trastuzumab Resistance
13.	Study On The Association And Molecular Mechanism Of LncRNA HOTAIR And Trastuzumab Resistance In Breast Cancer
14.	Exploring The Regulation Of Cyclin D3 By Trastuzumab And The Mechanism Of Trastuzumab Resistance In Breast Cell Line
15.	The Anti-tumor Effect Of Anti-ErbB2 Antibody H2-18 In Combination With Small Molecule Inhibitors On Trastuzumab-resistant Breast Cancer And Mechanism Of Action
16.	The Anti-tumor Effect Of Anti-HER2 Antibody H2-18 On Gastric Cancer And Its Mechanism
17.	The HER4-YAP1 Axis Promotes Trastuzumab Resistance In HER2 Positive Gastric Cancer By Inducing EMT Transition
18.	The Role And Mechanism Of EPHA5 In The Trastuzumab Resistance Of HER2-positive Breast Cancer
19.	Optimized Metformin And Trastuzumab Dosing Schedule Based On Circadian Dynamics Of Glucose Metabolism Overcome Trastuzumab Resistance In HER2-positive Gastric Cancer
20.	The Mechanism Of Trastuzumab Resistance In Breast Carcinomas With HER-2 Mutation Factors Influencing Non-sentinel Lymph Nodes Metastases Of Breast Cancer And Implications For Treatment
<<First <Prev Next> Last>> Jump to